Publications & Abstracts
Dec 28, 2009
Initial Human Experience with Restrictive Duodenal-Jejunal Bypass Liner for Treatment of Morbid Obesity
The aim of the present study was to evaluate the clinical effects and safety of the duodenal-jejunal bypass liner combined with a restrictor orifice...
Nov 30, 2009
Open-Label, Sham-Controlled Trial of an Endoscopic Duodenojejunal Bypass Liner for Preoperative Weight Loss in Bariatric Surgery Candidates
This 12-week, open-label, randomized trial investigated the use of the DJBL versus a sham upper endoscopy for weight loss before bariatric...
Nov 11, 2009
Pilot Clinical Study of an Endoscopic, Removable Duodenal-Jejunal Bypass Liner for the Treatment of Type 2 Diabetes
Obese T2DM subjects were randomized to receive a DJBL (n ¼ 12) or sham endoscopy (n ¼ 6) in a 24-week study, extended up to 52 weeks.
Videos
How EndoBarrier Works
EndoBarrier: Non-surgical Treatment for Patients with Type 2 Diabetes and …
Maintenance of Efficacy after EndoBarrier
UK First NHS EndoBarrier Service – Dr. Bob Ryder June …
BBC News Item
EndoBarrier treatment for diabetes & obesity following 1 year results …
